Kevin Coppa
YOU?
Author Swipe
View article: Utilization of transitional care management services and 30-day readmission
Utilization of transitional care management services and 30-day readmission Open
Transitional care management (TCM) visits have been shown to reduce 30-day readmissions, but it is unclear whether the decrease arises from the TCM visit itself or from clinic-level changes to meet the requirements of the TCM visits. We co…
View article: Longitudinal dynamic clinical phenotypes of in-hospital COVID-19 patients across three dominant virus variants in New York
Longitudinal dynamic clinical phenotypes of in-hospital COVID-19 patients across three dominant virus variants in New York Open
View article: Application of a Machine Learning Algorithm to Develop and Validate a Prediction Model for Ambulatory Non-Arrivals
Application of a Machine Learning Algorithm to Develop and Validate a Prediction Model for Ambulatory Non-Arrivals Open
View article: Development and validation of self-monitoring auto-updating prognostic models of survival for hospitalized COVID-19 patients
Development and validation of self-monitoring auto-updating prognostic models of survival for hospitalized COVID-19 patients Open
View article: Patient Symptom Extractor from History of Illness Notes (PSEHI): A Natural Language Processing Framework Applied on COVID-19 Presentation Notes During 2 Pandemic Waves in New York
Patient Symptom Extractor from History of Illness Notes (PSEHI): A Natural Language Processing Framework Applied on COVID-19 Presentation Notes During 2 Pandemic Waves in New York Open
View article: Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”
Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study” Open
View article: Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study” (Preprint)
Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study” (Preprint) Open
UNSTRUCTURED These are author responses to peer review associated with ms#29638
View article: Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study
Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study Open
Background Neutralizing monoclonal antibody (MAB) therapies may benefit patients with mild to moderate COVID-19 at high risk for progressing to severe COVID-19 or hospitalization. Studies documenting approaches to deliver MAB infusions and…
View article: External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19
External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19 Open
View article: Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study (Preprint)
Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study (Preprint) Open
BACKGROUND Neutralizing monoclonal antibody (MAB) therapies may benefit patients with mild to moderate COVID-19 at high risk for progressing to severe COVID-19 or hospitalization. Studies documenting approaches to deliver MAB infusions an…
View article: Early Experience With Neutralizing Monoclonal Antibody Therapy For COVID-19
Early Experience With Neutralizing Monoclonal Antibody Therapy For COVID-19 Open
Importance Neutralizing monoclonal antibody (MAB) therapies may benefit patients with mild to moderate COVID-19 at high risk for progressing to severe COVID-19 and/or hospitalization. Studies documenting approaches to deliver MAB infusions…
View article: Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19
Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19 Open
View article: Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19
Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19 Open
View article: Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration’s recommendation: a cross-sectional analysis in New York
Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration’s recommendation: a cross-sectional analysis in New York Open
Objective To describe the pattern of hydroxychloroquine use and examine the association between hydroxychloroquine use and clinical outcomes arising from changes in the US Food and Drug Administration (FDA)’s recommendation during the coro…
View article: Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients
Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients Open
Background We aimed to identify the prevalence and predictors of venous thromboembolism (VTE) or mortality in hospitalized coronavirus disease 2019 (COVID-19) patients. Methods A retrospective cohort study of hospitalized adult patients ad…
View article: Examination of Post-discharge Follow-up Appointment Status and 30-Day Readmission
Examination of Post-discharge Follow-up Appointment Status and 30-Day Readmission Open
View article: Machine learning to assist clinical decision-making during the COVID-19 pandemic
Machine learning to assist clinical decision-making during the COVID-19 pandemic Open
View article: A predictive model to estimate survival of hospitalized COVID-19 patients from admission data
A predictive model to estimate survival of hospitalized COVID-19 patients from admission data Open
Objective Our primary objective was to use initial data available to clinicians to characterize and predict survival for hospitalized coronavirus disease 2019 (COVID-19) patients. While clinical characteristics and mortality risk factors o…
View article: Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area Open
This case series provides characteristics and early outcomes of sequentially hospitalized patients with confirmed COVID-19 in the New York City area.